Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Rawlins

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
Pharmacoepidemiology and Drug Safety|July 1, 1997
Commentary: Should 'idiosyncrasy' be defined as equivalent to 'type B' adverse drug reactions? (Vol. 6: 213)M D Rawlins
British Medical Journal (Clinical Research Ed.)|February 6, 1988
Drug regulation: evolution or revolution?M D Rawlins
British Journal of Clinical Pharmacology|June 1, 1977
The role of the pharmaceutical industry in postgraduate medical educationM D Rawlins
Nature|January 18, 1996
Panic and the pillM D Rawlins
BMJ (Clinical Research Ed.)|February 23, 1991
Extending the role of the community pharmacistM D Rawlins
BMJ (Clinical Research Ed.)|February 27, 2001
The failings of NICE. Reply from chairman of NICEM D Rawlins
British Medical Journal (Clinical Research Ed.)|March 24, 1984
Postmarketing surveillance of adverse reactions to drugsM D Rawlins
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
Pharmacodynamic drug interactionsM D Rawlins
The Quarterly Journal of Medicine|February 1, 1985
Pharmocogenetic implications of polymorphic debrisoquine hydroxylationsM D Rawlins
British Journal of Clinical Pharmacology|July 1, 1988
Spontaneous reporting of adverse drug reactions. II: UsesM D Rawlins
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Pharmacoepidemiology and Drug Safety|July 1, 1997
Commentary: Should 'idiosyncrasy' be defined as equivalent to 'type B' adverse drug reactions? (Vol. 6: 213)M D Rawlins
British Medical Journal (Clinical Research Ed.)|February 6, 1988
Drug regulation: evolution or revolution?M D Rawlins
British Journal of Clinical Pharmacology|June 1, 1977
The role of the pharmaceutical industry in postgraduate medical educationM D Rawlins
Nature|January 18, 1996
Panic and the pillM D Rawlins
BMJ (Clinical Research Ed.)|February 23, 1991
Extending the role of the community pharmacistM D Rawlins
BMJ (Clinical Research Ed.)|February 27, 2001
The failings of NICE. Reply from chairman of NICEM D Rawlins
British Medical Journal (Clinical Research Ed.)|March 24, 1984
Postmarketing surveillance of adverse reactions to drugsM D Rawlins
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
Pharmacodynamic drug interactionsM D Rawlins
The Quarterly Journal of Medicine|February 1, 1985
Pharmocogenetic implications of polymorphic debrisoquine hydroxylationsM D Rawlins
British Journal of Clinical Pharmacology|July 1, 1988
Spontaneous reporting of adverse drug reactions. II: UsesM D Rawlins
Pageof 28